Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.

Study participants who went on an IgG-based elimination diet--based on a novel blood test--experienced less abdominal pain than those on a sham diet.

This important study explores the conserved role of IgM in both systemic and mucosal antiviral immunity in teleosts, challenging established views on the differential roles of IgT and IgM. The ...

A randomised trial finds that a targeted elimination diet based on IBS-specific IgG antibodies significantly improves ...

The study, published in Gastroenterology, tested a new IBS-specific blood test (InFoods IBS, Biomerica) that measures levels ...

Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to ...

Researchers are studying a new approach to HDFN prevention to reduce cases in countries where incidence rates remain high.

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...